Renal Cancer - Results from #3700

Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial. March 26, 2019

Serum Alpha1-Globulin as a Novel Prognostic Factor in Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors. March 26, 2019

Overexpression of FZD1 is Associated with a Good Prognosis and Resistance of Sunitinib in Clear Cell Renal Cell Carcinoma. March 26, 2019

Discovery of lipid biomarkers correlated with disease progression in clear cell renal cell carcinoma using desorption electrospray ionization imaging mass spectrometry. March 25, 2019

Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis. March 25, 2019

Influence of Tumor Thrombus on Occurrence of Distant Venous Thromboembolism and Survival in Patients With Renal Cell Carcinoma After Surgery. March 25, 2019

MicroRNA-218 inhibits the cell proliferation and migration in clear cell renal cell carcinoma through targeting cancerous inhibitor of protein phosphatase 2A. March 22, 2019

Silencing of the long non-coding RNA GHET1 inhibits cell proliferation and migration of renal cell carcinoma through epithelial-mesenchymal transition. March 22, 2019

Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma? March 22, 2019

18F-FPPRGD2 PET/CT in patients with metastatic renal cell cancer. March 21, 2019

Impact of E-Cadherin and β-Catenin as Prognostic Factor in Renal Cell Carcinoma with Tumor Thrombus of the Vena Cava. March 21, 2019

Treating the Chameleon: Radiotherapy in the management of Renal Cell Cancer. March 21, 2019

Activation of AMPK by metformin promotes renal cancer cell proliferation under glucose deprivation through its interaction with PKM2. March 20, 2019

TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway. March 20, 2019

The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy. March 20, 2019

The prognostic value of the site of invasion in T3aN0M0 clear cell renal cell carcinoma. March 19, 2019

The critical role of lymph node dissection in selecting high-risk nonmetastatic renal cancer candidates for adjuvant therapy after nephrectomy. March 19, 2019

Low Expression of ATM Indicates a Poor Prognosis in Clear Cell Renal Cell Carcinoma. March 19, 2019

RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma. March 18, 2019

NDNF inhibits the migration and invasion of human renal cancer cells through epithelial-mesenchymal transition. March 18, 2019

Page 186 of 456